DexCom (DXCM) PT Raised to $125 at Oppenheimer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall Street rallies as AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips below $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Wall Street rallies as AI optimism reignites and Treasury yields retreat
DexCom Executive Chairman and Director Terry Gregg Retires
August 1, 2018 4:10 PM EDTPresident and CEO Kevin Sayer Appointed Chairman of the Board
SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), the leader in continuous glucose... More
DexCom Reports Second Quarter 2018 Financial Results
August 1, 2018 4:01 PM EDTSAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended June 30, 2018.
Second Quarter 2018 Highlights:
Revenue grew 42% to $242.5 million versus the same quarter of the prior year US revenue grew 35% versus the same quarter of the prior year International revenue grew 78% on a reported basis versus the same quarter of the prior year GAAP net income of $30.2 million, or $0.34 per share... More